TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive New Ethics Rules Stir Anger, Disaffection at NIH, Scientists to Prepare a Legal Challenge. February 11, 2005